CBFAX
Price
$42.88
Change
+$0.24 (+0.56%)
Updated
Jun 2 closing price
Net Assets
32.41B
CIRAX
Price
$82.35
Change
+$0.47 (+0.57%)
Updated
Jun 2 closing price
Net Assets
126.77B
Interact to see
Advertisement

CBFAX vs CIRAX

Header iconCBFAX vs CIRAX Comparison
Open Charts CBFAX vs CIRAXBanner chart's image
CBFAX vs CIRAX Comparison Chart in %
View a ticker or compare two or three
VS
CBFAX vs. CIRAX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBFAX is a Buy and CIRAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIRAX has more cash in the bank: 127B vs. CBFAX (32.4B). CIRAX pays higher dividends than CBFAX: CIRAX (2.70) vs CBFAX (2.15). CBFAX was incepted earlier than CIRAX: CBFAX (15 years) vs CIRAX (24 years). CBFAX (0.83) is less costly to investors than CIRAX (0.60). CBFAX (50.00) and CIRAX (50.00) have comparable annual turnover. CBFAX (4%) and CIRAX (4%) have equivalent initial investment costs. CBFAX (250) and CIRAX (250) have matching initial minimum investment requirements. CBFAX (12.61) and CIRAX (12.57) have marching annual gain over last year. CIRAX return over 5 years is better than : 39.24 vs. CBFAX (18.76).
CBFAXCIRAXCBFAX / CIRAX
Total Expense Ratio0.830.60138%
Annual Report Gross Expense Ratio0.830.60138%
Fund Existence15 years24 years-
Gain YTD6.3537.16789%
Front Load4%4%100%
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets32.4B127B26%
Annual Yield % from dividends2.152.7080%
Returns for 1 year12.6112.57100%
Returns for 3 years32.5441.4878%
Returns for 5 years18.7639.2448%
Returns for 10 years71.9994.7576%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSMMX21.84N/A
N/A
Invesco Summit C
LMCFX36.53N/A
N/A
Lord Abbett Mid Cap Stock F
TSLIX6.40N/A
N/A
Transamerica Small Cap Value I
RSGRX38.22N/A
N/A
Victory RS Growth A
JUEQX28.51N/A
N/A
JPMorgan US Equity R4